Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

Scientists identify new potential drug for treating acute myeloid leukaemia

Scientists identify new potential drug for treating acute myeloid leukaemia

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

Encouraging results from Semafore Pharmaceuticals' SF1126 Phase I dose-escalation trial for myeloma

Encouraging results from Semafore Pharmaceuticals' SF1126 Phase I dose-escalation trial for myeloma

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Two abstracts describing preclinical studies with GMI-1070 selected for oral presentations

Two abstracts describing preclinical studies with GMI-1070 selected for oral presentations

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Data from two phase Ib clinical trials of dacetuzumab for DLBCL reported

Data from two phase Ib clinical trials of dacetuzumab for DLBCL reported

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Study data of Perifosine + Bortezomib combination in multiple myeloma patients presented

Study data of Perifosine + Bortezomib combination in multiple myeloma patients presented

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

New three-drug combination may be effective for treating patients with bone cancer

New three-drug combination may be effective for treating patients with bone cancer

Researchers explore optimal induction therapies for managing blood cancer

Researchers explore optimal induction therapies for managing blood cancer